中国人一个显性视网膜色素变性家系8号染色体连锁分析

目的用连锁分析法对中国人一个显性视网膜色素变性家系8号染色体进行分析，确定致病基因。方法随机选取8号染色体RP1基因上下约10厘摩(cm)范围内的10对微卫星标记(marker)，确立单倍体型，用两点法计算最大优势对数(LOD SCORE)值。结果所选微卫星标记与该家系表型间最大LOD值小于1。结论RP1基因可能为该家系的非致病性基因，用连锁分析法进行致病基因排除对最终确立致病基因所在染色体的范围具有重要的价值。     

一个常染色体显性遗传视网膜色素变性家系疾病基因排除性定位分析

目的 确定一个常染色体显性遗传视网膜色素变性(autosomal dominantret initis pigmentosa,ADRP)家系中的疾病基因与3号染色体视紫红质基因的关系。方法 选择一个连续5代发病的ADRP家系,采集到该家系中16个正常个体、18个受累个体的血样。选取3号染色体上的14对用6-FAM、HEX、NED3种荧光染料标记的微卫星标记DNA引物,对该家系进行连锁分析。结果 3号染色体上的14对微卫星NDA标记位点的LOD值均≤-2,证实3号染色体上的14对微卫星标记DNA位点与该家系致病基因不连锁。结论 该家系的致病基因位于其他染色体上。     

东北地区一遗传性白内障家系的临床遗传学及基因定位研究

目的:分析一先天性核型白内障家系的遗传方式及致病基因所在位置。方法:收集一个3代遗传性白内障家系成员的临床资料;提取家系成员外周血DNA,选取62个态性微卫星标记进行连锁分析。应用LINKAGE软件(version 5.2)中的MLINK程序计算两点连锁LOD值,并人工构建家系成员的单体型。结果:确定该家系为一常染色体显性遗传性白内障大家系,在微卫星标记D22S689可获得最大LOD值2.71(θ=0时),单体型提示该家系表型可能与染色体22q11.2-12.1区域连锁。该区域含有CRYBB1,CRYBB2,CRYBB3,CRYBA44个候选基因。结论:本研究先天性核型白内障家系符合常染色体显性遗传规律,其致病基因定位于22q11.2-12.1区域。     

常染色体显性遗传性先天性白内障一家系致病基因的初步定位

目的 初步定位常染色体显性遗传性先天性白内障(ADCC)一家系的致病基因。方法 收集ADCC一家系资料,在已知先天性白内障致病基因和位点附近,选择合适的短串联重复序列多态性标记(STRP),对ADCC一家系进行连锁分析,使用Mlink软件采用对数优势记分法(LOD)计算LOD值。结果 在STRP中,D17S805、D17S1294及D17S1293与致病基因位点连锁的最大LOD值分别为2．03、2．49及2．22(重组率0=0)。结论 该ADCC家系的致病基因初步定位在第17对染色体上;CRYBA1基因为候选基因。（中华眼科杂志,2004,40：824-827)     

Avellino角膜营养不良家系致病基因的定位研究

目的：对收集到的一个常染色体显性遗传性Avellino角膜营养不良家系的致病基因进行初步定位。
　　方法：采集家系中所有成员的外周静脉血,从中提取基因组DNA样本。在热点区域内选取微卫星标记进行基因扫描,分别利用LINKAGE软件和CYRILLIC软件进行连锁分析及单体型分析,以确定候选基因所在的染色体区域。
　　结果：该Avellino角膜营养不良家系的连锁分析结果在D5 S396和D5 S393这两个微卫星标记处获得最大优势对数计分(LOD)值,Zmax=3.01(θ=0.00)。单体型分析将致病基因定位于微卫星标记D5 S808和D5 S638之间。
　　结论：该Avellino角膜营养不良家系的致病基因初步定位于染色体5q上的遗传距离约为11.2厘摩( cM)的一段区域内。     

先天性白内障一家系致病基因的排除性定位

目的 明确一个国人常染色体显性先天性白内障（ADCC）家系致病基因的染色体位点是否位于已知的22个非综合征型ADCC致病位点内，从而初步定位该ADCC家系致病基因的染色体位点。设计 家系遗传研究。研究对象 一个先天性白内障家系。方法 对26例家系成员中的16例进行临床检查、采集静脉血样、提取基因组DNA；在已知的22个非综合征型ADCC致病位点内，分别选取3-6个多态性微卫星标记，对该ADCC家系进行遗传连锁分析。主要指标 先天性白内障临床表型、Lod值。结果 该家系患者为晶状体前囊膜及前囊膜下混浊；所有多态性微卫星标记与致病基因两点间的Lod值均≤-2，证实微卫星标记所在的染色体区域与该ADCC家系的致病基因不连锁。结论 该ADCC家系致病基因的染色体位点不在已知的22个非综合征型ADCC致病位点内，可能是一个新的致病基因导致了该家系的临床表型。     

先天性核性白内障家系致病基因的定位与候选基因突变检测

目的 对中国一常染色体显性遗传性先天性核性白内障家系进行致病基因的定位与候选基因突变检测.方法 实验研究.采集家系成员的外周静脉血,提取基因组DNA.用约400个中密度微卫星标记进行基因扫描,平均遗传距离10厘摩(cM).利用LINKAGE软件包进行连锁分析.在阳性定位区域内选取更为精细的微卫星标记进行精细定位.利用CYRILLIC软件进行单体型分析,确定候选基因所在染色体区域.候选基因直接测序检测基因突变.结果两点间连锁分析在微卫星标记D2S325处获得最大对数优势计分(LOD)值Zmax=2.29(θmax=0.00).精细定位和单体型分析将致病基因定位于微卫星标记D2S117和D2S2382之间,遗传距离约19.04 cM,染色体位置为2q32.3-q35.候选基因直接测序发现CRYGC基因第3外显子第470碱基一个G→A的点突变.结论本研究将我国一个先天性核性白内障家系的致病基因定位于2号染色体2q32.3-q35约19.04cM区域内,并在CRYGC基因发现一个新的点突变与此家系共分离.(中华眼科杂志,2009,45:234-238)     

马凡综合征一家系的临床研究及致病基因连锁分析

目的研究一个中国人马凡综合征(Marfan sydrome,MFS)家系的临床特点,并通过基因连锁分析的方法对该家系的致病基因进行定位研究。方法收集一个MFS家系,对家系所有成员进行全面详细的眼科及全身临床检查。确定其临床表型及遗传方式后,在位于MFS的已知基因FBN1、TGFBR1、TGFBR2附近选取微卫星标记物进行连锁分析。经ABI3130型遗传分析仪、Genscan2.1收集数据,Genotyper2.1进行基因分型,Link-age软件计算两点LOD值。结果该家系的遗传方式为常染色体显性遗传,家系中所有患者均具有典型的晶状体脱位、高度近视及MFS的特征性骨骼改变。仅有2例患者表现为心血管系统的异常。与该家系连锁的染色体微卫星标记物为D3S1609和D3S2432,其最大的LOD值为3.22。结论此家系为常染色体显性遗传型MFS,其致病基因位于3号染色体的D3S1609和D3S2432之间,位于该区间内的已知基因TGFBR2的突变可能是导致该家系致病的分子基础。     

先天性眼外肌纤维化一家系致病基因的连锁分析

目的分析一个中国人先天性眼外肌纤维化(congenital fibrosis of extraocularmuscles,CFEOM)家系的临床表型,并通过基因连锁分析的方法对该家系的致病基因进行定位研究。方法收集一个CFEOM家系,对家系所有成员进行详细的临床检查。确定其临床表型及遗传方式后,在位于11号染色体的已知CFEOM基因附近选取微卫星标记物进行连锁分析。运用MILINK软件计算最大优势对数LOD值。结果该家系的遗传方式为常染色体隐性遗传,家系中的5例患者均表现为典型的眼外肌纤维化特征。与该家系连锁的染色体微卫星标记物为D11S4151和D11S1320,其最大的LOD值为1.21。结论此家系为常染色体隐性遗传型CFEOM2型,其致病基因位于11号染色体的D11S4151和D11S1320之间,位于该区间内的已知基因PHOX2A/ARIX的突变可能是导致该家系致病的分子基础。     

一个常染色体显性遗传先天性白内障家系致病基因筛查

目的: 对中国一个常染色体显性遗传先天性白内障家系(ADCC)的已知候选基因进行筛查以寻找致病位点。方法: 收集一个ADCC家系的临床资料并采集静脉血。在24个已知与ADCC相关基因附近选择微卫星标记,利用Linkage软件Mlink软件包进行连锁分析计算Lod值。结果: 此家系白内障类型为核性白内障,24个候选基因附近50个微卫星Lod值均小于0,微卫星所在区域与此家系致病基因无连锁关系。结论: 此ADCC家系致病基因不是已知的与ADCC相关基因,可能是一个新的致病基因突变导致此家系疾病发生。     

Molecular analysis of the rhodopsin gene in southern France: identification of the first duplication responsible for retinitis pigmentosa,c.998^999ins4

Purpose: Mutations in the gene encoding rhodopsin, the visual pigment in rod photoreceptors, were shown to be the most common cause of autosomal retinitis pigmentosa (RP). In order to determine the prevalence of rhodopsin alterations in southern French populations, we examined 52 unrelated patients/families with autosomal dominant RP (adRP=29), RP simplex (6), or unclassified RP (17). Methods: The full coding and flanking sequences of the rhodopsin (RHO) gene were scanned using an improved DGGE (denaturing gradient gel electrophoresis) assay, followed by sequencing of abnormal fragments. Results: This study revealed three RHO mutations in patients with adRP (G106R, R135W, and c.998^999ins4) and a number of frequent or rare polymorphisms. No disease-causing sequence variation was found in simplex and unclassified RP pedigrees. Mutation c.998^999ins4 has not been previously reported, and appears as the first duplication identified so far in the RHO gene. This frameshift mutation, which is associated with a severe RP, alters the carboxy terminus and predicts a 353-amino acid mutant rhodopsin instead of 348. Discussion: Our study demonstrates that rhodopsin mutations are responsible for only 10.3% of adRP in French populations living in the Mediterranean area in contrast to the 25-35% reported in other populations.     

A novel mutation of the RP1 gene (Lys778ter) associated with autosomal dominant retinitis pigmentosa

BACKGROUND: Besides the three known genes (RHO, RDS/Peripherin, NRL) involved in autosomal dominant retinitis pigmentosa (adRP), a fourth gene, RP1, has been recently identified. Initial reports suggest that mutations in the RP1 gene are the second most frequent cause of adRP. The clinical findings were described in a family with adRP and a novel mutation in the RP1 gene. METHOD: Index patients from 15 independent families with adRP in which RHO mutations had been excluded in previous examinations were screened for mutations in the RP1 gene by means of direct DNA sequencing. Evaluation of the RP1 phenotype in patients included funduscopy, kinetic perimetry, dark adapted final threshold test, standard electroretinography and, in one case, multifocal electroretinography. RESULTS: One novel nonsense mutation (Lys778ter) in one of these 15 patients was detected. Cosegregation of the mutation with the disease phenotype could be established in the index patient's family. The phenotype comprises variable expression of clinical disease probably including one case of incomplete penetrance, a onset of symptoms beginning in adulthood, and evidence of regionally varying retinal function loss. CONCLUSION: The Lys778ter mutation localises inside the critical region harbouring all mutations described so far. The ophthalmic findings support previous observations that variation of disease expression appears as a typical feature of the RP1 phenotype.     

Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families

PURPOSE: To survey families with clinical evidence of autosomal dominant retinitis pigmentosa (adRP) for mutations in genes known to cause adRP. METHODS: Two hundred adRP families, drawn from a cohort of more than 400 potential families, were selected by analysis of pedigrees. Minimum criteria for inclusion in the adRP cohort included either evidence of at least three generations of affected individuals or two generations with evidence of male-to-male transmission. Probands from each family were screened for mutations in 13 genes known to cause adRP: CA4, CRX, FSCN2, IMPDH1, NRL, PRPF3 (RP18), PRPF8 (RP13), PRPF31 (RP11), RDS, RHO, ROM1, RP1, and RP9. Families without mutations in autosomal genes and in which an X-linked mode of inheritance could not be excluded were tested for mutations in ORF 15 of X-linked RPGR. Potentially pathogenic variants were evaluated based on a variety of genetic and computational criteria, to confirm or exclude pathogenicity. RESULTS: A total of 82 distinct, rare (nonpolymorphic) variants were detected among the genes tested. Of these, 57 are clearly pathogenic based on multiple criteria, 10 are probably pathogenic, and 15 are probably benign. In the cohort of 200 families, 94 (47%) have one of the clearly pathogenic variants and 10 (5%) have one of the probably pathogenic variants. One family (0.5%) has digenic RDS-ROM1 mutations. Two families (1%) have a pathogenic RPGR mutation, indicating that families with apparent autosomal transmission of RP may actually have X-linked genetic disease. Thus, 107 families (53.5%) have mutations in known genes, leaving 93 whose underlying cause is still unknown. CONCLUSIONS: Together, the known adRP genes account for retinal disease in approximately half of the families in this survey, mostly Americans of European origin. Among the adRP genes, IMPDH1, PRPF8, PRPF31, RDS, RHO, and RP1 each accounts for more than 2% of the total; CRX, PRPF3, and RPGR each accounts for roughly 1%. Disease-causing mutations were not found in CA4, FSCN2, NRL, or RP9. Because some mutations are frequent and some regions are more likely to harbor mutations than others, more than two thirds of the detected mutations can be found by screening less than 10% of the total gene sequences. Among the remaining families, mutations may lie in regions of known genes that were not tested, mutations may not be detectable by PCR-based sequencing, or other loci may be involved.     

Autosomal dominant retinitis pigmentosa in Norway: a 20-year clinical follow-up study with molecular genetic analysis. Two novel rhodopsin mutations: 1003delG and I179F

PURPOSE: To examine the clinical picture and molecular genetics of 12 Norwegian families with autosomal dominant retinitis pigmentosa (adRP) in order to achieve a genotype-phenotype correlation. METHODS: In addition to a clinical ophthalmological examination, fundus photography, dark adaptometry and electroretinography were performed. Four genes were analysed: rhodopsin (RHO); retinitis pigmentosa 1 (RP1); retinal degeneration slow/peripherin (RDS/peripherin), and inosine monophosphate dehydrogenase 1 (IMPDH1). Seven of the families had been examined about 20 years previously. A total of 63 patients or first-degree relatives (aged 18-79 years) were examined. RESULTS: Mutations were found only in the RHO gene. Seven families were given a diagnosis of classical RP. Two of them had novel mutation 1003delG, and one family had the mutation V345M. Four families had pericentral retinal dystrophy (PRD), two families with the mutation A164V and one with novel mutation I179F. One family was given a diagnosis of central and pericentral retinal dystrophy (CPRD), a special type of cone/rod dystrophy, and no mutation was found. CONCLUSIONS: Six of 12 families had an RHO mutation. The mutation V345M and the novel mutation 1003delG both caused classical RP, the former indicating the most unfavourable prognosis. Two of the families with PRD had the A164V mutation with a favourable prognosis, whereas the novel mutation I179F caused PRD with extremely variable expressivity.     

Mutations in the pre-mRNA splicing-factor genes PRPF3, PRPF8, and PRPF31 in Spanish families with autosomal dominant retinitis pigmentosa

PURPOSE: Mutations in the systemically expressed pre-mRNA splicing-factor genes PRPF3, PRPF8, and PRPF31 have recently been associated with autosomal dominant retinitis pigmentosa (adRP). This study was intended to identify mutations in PRPF3, PRPF8, and PRPF31 in 150 Spanish families affected by adRP, to measure the contribution of mutations in these genes to adRP in that population, and to correlate RP phenotype expression with mutations in pre-mRNA splicing-factor genes. METHODS: Denaturing gradient gel electrophoresis (DGGE) and direct genomic sequencing were used to evaluate the complete coding region and flanking intronic sequences of the PRPF31 gene, exon 42 of PRPF8, and exon 11 of PRPF3 for mutations in 150 unrelated index patients with adRP. Ophthalmic and electrophysiological examination of patients with RP and their relatives was performed according to preexisting protocols. RESULTS: Three nonsense mutations caused by insertion and deletion sequences and two missense mutations (Arg2310Gly) and within the stop codon of the PRPF8 gene (TGA-->TTG), were detected in five unrelated heterozygous patients. Three patients were heterozygous carriers of different nonsense mutations in exon 8 of the PRPF31, gene and one Thr494Met mutation was found in exon 11 of the PRPF3 gene. Cosegregation of the mutation in PRPF8 and PRPF3 with adRP was observed. However, two nonsense mutations in PRPF31 causing adRP detected in two families showed asymptomatic carriers. CONCLUSIONS: Nine mutations, six of which are novel, in the pre-mRNA splicing-factor genes PRPF3, PRPF8, and PRPF31, causing adRP have been identified in the Spanish population. Their contribution to adRP is approximately 5% after correction in relation to mutations found in other genes causing adRP. The patients carrying a mutation in the pre-mRNA splicing-factor PRPF8 gene showed a type 1 diffuse RP. The existence of asymptomatic carriers of the nonsense mutation in the PRPF31 gene suggests incomplete penetrance for these mutations in the families.     

A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa

Mutational heterogeneity in genes causative of dominantly inherited disorders represents a significant barrier for development of therapies directed towards correction of the primary genetic defect. To circumvent the mutational heterogeneity present in rhodopsin- (RHO-) linked autosomal dominant Retinitis Pigmentosa (adRP), a strategy involving suppression and replacement of RHO has been adopted. RNA interference- (RNAi-) mediated suppression of RHO has been explored as has the generation of an RNAi-resistant replacement gene using the degeneracy of the genetic code. Additionally, the functional equivalence of codon-modified replacement genes has been demonstrated in a transgenic animal (RHO-M). Suppression and replacement, while exemplified by adRP, may also be relevant to many other dominantly inherited diseases with the hallmark of mutational heterogeneity.     

Rhodopsin C110Y mutation causes a type 2 autosomal dominant retinitis pigmentosa

Purpose: The RHO C110Y mutation has been recently reported to cause a phenotypically unspecified form of autosomal dominant retinitis pigmentosa (adRP). The study of a family affected with this mutation allowed us to hereby describe the genotype/phenotype correlation associated with the RHO C110Y mutation. Methods: A six-generation pedigree cosegregating adRP and RHO C110Y in ten accessible individuals was ophthalmologically investigated. All family members affected with RP went through complete eye examination and ERG testing. Results: The disease first manifested with nyctalopia during adulthood and slowly progressed over the next decades towards tubular visual field defects and relatively preserved central vision. Ophthalmoscopically, the fundus remained almost unaltered until the end of the third decade of life, and then slowly progressed towards typical RP changes with minimal macular involvement by the eighth decade. Color vision remained unaltered. Earliest ERG alteration was limited to the rod system followed by a rod-cone pattern. Scotopic and photopic ERG were recordable until the fourth and sixth decades, respectively. Discussion: RHO C110Y-associated adRP is characterized by a late onset and a mild progression compatible with type 2 or regional RP with little intrafamilial phenotypic variability and complete penetrance. Characterization of genotype-phenotype correlations plays a role in the improvement of genetic and prognostic counselling.     

Mutation c. 1142 del G in the <Emphasis Type="Italic">PRPF31</Emphasis> Gene in a Family with Autosomal Dominant Retinitis Pigmentosa (RP11) and Its Implications

Purpose

To identify a mutation in the PRPF31 gene in a family (Family K) with autosomal dominant retinitis pigmentosa (adRP) linked to 19q13.4 (RP11) and to find the frequency of mutations in the PRPF31 gene among Japanese families with adRP.

Methods

Genomic DNA specimens were prepared from five symptomatic and two asymptomatic members of Family K and an additional 39 patients of 39 unrelated families with adRP. Coding regions of the PRPF31 gene were amplified by polymerase chain reaction. The amplicons were analyzed by a direct sequencing method.

Results

All seven family members had a heterozygous c.1142delG mutation in the PRPF31 gene, which was identical to the mutation previously reported in a different Japanese family. No other mutation was found in the PRPF31 gene among the 39 additional patients with adRP.

Conclusion

Although the frequency of mutations in the PRPF31 gene is about 2.5% in Japanese families with adRP, it is possible that c.1142delG is a common mutation among Japanese patients with adRP associated with mutations in the PRPF31 gene.?Jpn J Ophthalmol 2007;51:45–48 © Japanese Ophthalmological Society 2007